# Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)

> **NCT00295789** · PHASE3 · COMPLETED · sponsor: **Haruhiko Fukuda** · enrollment: 253 (actual)

## Conditions studied

- Uterine Cervical Neoplasms

## Interventions

- **DRUG:** chemotherapy: Paclitaxel/Cisplatin
- **DRUG:** chemotherapy: Paclitaxel/Carboplatin

## Key facts

- **NCT ID:** NCT00295789
- **Lead sponsor:** Haruhiko Fukuda
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 253 (ACTUAL)
- **Last updated:** 2016-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00295789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00295789, "Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00295789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*